Difference in non-weight-bearing effects on bone mineral density between trunk and peripheral fat mass in women with polycystic ovary syndrome

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 2, 2010, Pages 352-356

  Yanazume, Yumi ^a   Kawamura, Yukie ^a   Kuwahata, Akiko ^a   Yonehara, Yukie ^a   Matsuo, Takashi ^a   Iwamoto, Ichiro ^a   Douchi, Tsutomu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Non weight bearing effect; Peripheral fat mass; Polycystic ovary syndrome; Trunk fat mass

Indexed keywords

ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; TESTOSTERONE BLOOD LEVEL; TRUNK; WEIGHT BEARING;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; BODY FAT DISTRIBUTION; BODY MASS INDEX; BONE DENSITY; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; WEIGHT-BEARING;

EID: 77950202549     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01133.x     Document Type: Article

References (24)

1. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995 Suppl 2 187S 194S.
2. DiCarlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacob HS. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 1992 57 : 314 319.
3. Adami S, Zamberlan N, Castello R, Tosi F, Gatti D, Moghetti P. Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turn over in young women. Clin Endocrinol (Oxf) 1998 48 : 169 173.
4. Yuksel O, Dokmetas HS, Topcu S, Erselcan T, Sencan M. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab 2001 19 : 257 262.
5. Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol 2001 98 : 445 449.
6. Douchi T, Ijuin H, Nakamura S, Oki T, Yamamoto S, Nagata Y. Body fat distribution in women with polycystic ovary syndrome. Obstet Gynecol 1995 86 : 516 519.
7. Oh KW, Lee WY, Rhee EJ et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005 63 : 131 138.
8. Franklin RM, Ploutz-Snyder L, Kanaley JA. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 2009 58 : 311 315.
9. Killinger DW, Perel E, Daniilescu D, Kharlip L, Lindsay WR. The relationship between aromatase activity and body fat distribution. Steroids 1987 50 : 61 72.
10. Talbott EO, Zborowski JV, Boudreaux MY, McHugh-Pemu KP, Sutton-Tyrrell K, Guzick DS. The relationship between C-reactive protein and carotid intimal-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004 89 : 6061 6067.
11. Cascella T, Palomba S, De Sio I et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 2008 23 : 153 159.
12. De Simon M, Verrotti A, Iughetti L et al. Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin in massively obese adolescent girls. J Endocrinol Invest 2001 24 : 438 444.
13. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994 78 : 1515 1520.
14. Kirschner MA, Samojlik E. Sex hormone metabolism in upper and lower body obesity. Int J Obes 1991 15 (Suppl 2 101 108.
15. De Pergola G, Triggiani V, Giorgino F et al. The free testosterone to dehydroepiandrosterone sulfate molar ratio as a marker of visceral fat accumulation in premenopausal women. Int J Obes Relat Metab Disord 1994 18 : 659 664.
16. Miller KK, Biller BM, Beauregard C et al. Effect of testosterone replacement in androgen-deficient women with hypopituitarism: A randomized double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006 91 : 1683 1690.
17. Yamasaki H, Douchi T, Nagata Y. Changes in anthrometry with testosterone therapy in a female with gender identity disorder. Endocr J 2003 50 : 729 731.
18. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 2002 77 (Suppl 4 S34 S41.
19. Burr DB. Muscle strength, bone mass and age-related bone loss. J Bone Miner Res 1997 12 : 1547 1551.
20. Lu TW, O'Connor JJ, Taylor SJG, Walker PS. Influence of muscle activity of the forces of the femur: Comparison between in vivo measurements and calculation. Trans Orthop Res Soc 1997 22 : 721.
21. Dixon JE, Rodin A, Murby B, Chapman MG, Fogelman I. Bone mass in hirsute women with androgen excess. Clin Endocrinol (Oxf) 1989 30 : 271 277.
22. Kasperk CH, Wergedal JE, Farley JR. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989 124 : 1576 1578.
23. Vermeulen A, Kaufman JM, Goemaere S, Van Pottelberg I. Estradiol in elderly men. Aging Male 2002 5 : 98 102.
24. Barbieri RL. Hormone treatment of endometriosis: The estrogen threshold hypothesis. Am J Obstet Gynecol 1992 166 : 740 745.